Important notification
30.06.2016 To the attention of interested persons In line with provisions of Article 814 paragraph 4 of Law 95/2006 and […]
Press release
29.06.2016 To the attention of interested persons EMA press release on start of review of medicines manufactured at Pharmaceutics International […]
Press release
29.06.2016 To the attention of interested persons EMA press release: Studies from Alkem Laboratories Ltd cannot be used to support […]
Press release
29.06.2016 To the attention of interested persons EMA warns that Noxafil tablets and oral suspension have different doses and are […]
Press release
29.06.2016 To the attention of interested persons EMA press release: Adempas not for use in patients with pulmonary hypertension caused […]
Important notification
23.06.2016 To the attention of all wholesale distributors of medicinal products Please be advised that the national Czech authority has […]
Important notification
15.06.2016 To the attention of Marketing Authorisation Holders (MAHs)/MAH representatives EMA press release on Periodic Safety Update Report (PSUR) repository […]
Important notification
15.06.2016 To the attention of interested persons Considering that, lately information related to the lack of efficacy of generics, explicitly […]
Press release
15.06.2016 To the attention of interested persons EMA press release: Single, central platform now mandatory for all periodic safety update […]
Press release
30.05.2016 To the attention of interested persons EMA press release: Improving safety of first-in-human clinical trials download document …